BELGIAN BIOSAFETY SERVER
-- ANTIBIORESISTANCE ARCHIVE --
[Main Page]
[Aminoglycoside resistance]
ant(3'')-Ia gene
ID ECAAD standard; DNA; PRO; 1444 BP.
XX
AC X02340; M10241;
XX
NI g40880
XX
DT 02-JUL-1986 (Rel. 09, Created)
DT 17-FEB-1997 (Rel. 50, Last updated, Version 5)
XX
DE E. coli R538-1 plasmid aadA gene
DE for aminoglycoside 3" adenyltransferase AAD(3")(9)
XX
KW aminoglycoside 3" adenyltransferase; spectinomycin resistance;
KW streptomycin resistance; transferase.
XX
OS Escherichia coli
OC Eubacteria; Proteobacteria; gamma subdivision; Enterobacteriaceae;
OC Escherichia.
XX
OG Plasmid R538-1
XX
RN [1]
RP 1-1444
RX MEDLINE; 85191077.
RA Hollingshead S.K., Vapnek D.;
RT "Nucleotide Sequence Analysis of a Gene Encoding a
RT Streptomycin/Spectinomycin Adenyltransferase";
RL Plasmid 13:17-30(1985).
XX
RN [2]
RP 256-258
RA Hollingshead S.;
RT ;
RL Submitted (19-MAR-1986) to the EMBL/GenBank/DDBJ databases.
XX
DR SWISS-PROT; P04826; S3AD_ECOLI.
XX
CC Data kindly reviewed (19-MAR-1986) by S. Hollingshead
XX
FH Key Location/Qualifiers
FH
FT source 1..1444
FT /organism="Escherichia coli"
FT /plasmid="Plasmid R538-1"
FT -35_signal 132..137
FT /note="putative"
FT -35_signal 139..144
FT /note="putative"
FT -10_signal 156..162
FT /note="putative"
FT -10_signal 161..167
FT /note="putative"
FT RBS 208..215
FT /note="pot. rRNA binding site"
FT CDS 223..1194
FT /db_xref="PID:g581035"
FT /db_xref="SWISS-PROT:P04826"
FT /product="put. AAD (3)(9) precursor"
FT /translation="MVTAQWRFSWLLVMTCFFGVQSMPRASKQQARYAVGRCLMLWSSN
FT DVTQQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKP
FT HSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPA
FT KRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDL
FT FEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQ
FT PVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK"
FT sig_peptide 223..297
FT mat_peptide 298..1191
FT /product="put. AAD"
FT old_sequence 255..256
FT /citation=[1]
FT /replace="tcttg"
FT misc_feature 415..417
FT /note="pot. altern. translation initiation (GTG)"
XX
SQ Sequence 1444 BP; 360 A; 355 C; 392 G; 337 T; 0 other;
GGCCTGACGA TGCGTGGAGA CCGAAACCTT GCGCTCGTTC GCCACGCCAG GACAGAAATG 60
CCTCGACTTC GCTGCTGCCC AAGGTTGCCG GGTGACGCAC ACCGTGGAAA CGGATGAAGG 120
CACGAACCCA GTGGACATAA GCCTCGTTCG GTTCGTAAGC TGTAATGCAA GTAGCGTAAC 180
TGCCGTCACG CAACTGGTCC AGAACCTTGA CCGAACGCAG CGGTGGTAAC GGCGCAGTGG 240
CGGTTTTCAT GGCTTCTTGT TATGACATGT TTTTTTGGGG TACAGTCTAT GCCTCGGGCA 300
TCCAAGCAGC AAGCGCGTTA CGCCGTGGGT CGATGTTTGA TGTTATGGAG CAGCAACGAT 360
GTTACGCAGC AGGGCAGTCG CCCTAAAACA AAGTTAAACA TCATGAGGGA AGCGGTGATC 420
GCCGAAGTAT CGACTCAACT ATCAGAGGTA GTTGGCGTCA TCGAGCGCCA TCTCGAACCG 480
ACGTTGCTGG CCGTACATTT GTACGGCTCC GCAGTGGATG GCGGCCTGAA GCCACACAGT 540
GATATTGATT TGCTGGTTAC GGTGACCGTA AGGCTTGATG AAACAACGCG GCGAGCTTTG 600
ATCAACGACC TTTTGGAAAC TTCGGCTTCC CCTGGAGAGA GCGAGATTCT CCGCGCTGTA 660
GAAGTCACCA TTGTTGTGCA CGACGACATC ATTCCGTGGC GTTATCCAGC TAAGCGCGAA 720
CTGCAATTTG GAGAATGGCA GCGCAATGAC ATTCTTGCAG GTATCTTCGA GCCAGCCACG 780
ATCGACATTG ATCTGGCTAT CTTGCTGACA AAAGCAAGAG AACATAGCGT TGCCTTGGTA 840
GGTCCAGCGG CGGAGGAACT CTTTGATCCG GTTCCTGAAC AGGATCTATT TGAGGCGCTA 900
AATGAAACCT TAACGCTATG GAACTCGCCG CCCGACTGGG CTGGCGATGA GCGAAATGTA 960
GTGCTTACGT TGTCCCGCAT TTGGTACAGC GCAGTAACCG GCAAAATCGC GCCGAAGGAT 1020
GTCGCTGCCG ACTGGGCAAT GGAGCGCCTG CCGGCCCAGT ATCAGCCCGT CATACTTGAA 1080
GCTAGACAGG CTTATCTTGG ACAAGAAGAA GATCGCTTGG CCTCGCGCGC AGATCAGTTG 1140
GAAGAATTTG TCCACTACGT GAAAGGCGAG ATCACCAAGG TAGTCGGCAA ATAATGTCTA 1200
ACAATTCGTT CAAGCCGACG CCGCTTCGCC GGCGTTAACT CAAGCGATTA GATGCACTAA 1260
GCACATAATT GCTCACAGCC AAACTATCAG GTCAAGTCTG CTTTTATTAT TTTTAAGCGT 1320
GCATAATAAG CCCTACACAA ATTGGGAGAT ATATCATGAA AGGCTGGCTT TTTCTTGTTA 1380
TCGCAATAGT TGGCGAAGTA ATCGCAACAT CCGCATTAAA ATCTAGCGAG GGCTTTCTAA 1440
GCTT 1444
//
BELGIAN BIOSAFETY SERVER
-- ANTIBIORESISTANCE ARCHIVE --
[Main Page]
[Aminoglycoside resistance]